本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anaptysbio Inc

18.51
-0.7800-4.04%
盘后18.50-0.0100-0.05%19:54 EDT
成交量:85.33万
成交额:1,586.80万
市值:5.68亿
市盈率:-3.62
高:19.36
开:18.67
低:18.06
收:19.29
数据加载中...
2021/10/04

重要事件披露

8-K - Current report
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/17

重要事件披露

8-K - Current report
2021/06/03

重要事件披露

8-K - Current report
2021/05/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/04

重要事件披露

8-K - Current report
2021/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/12

重要事件披露

8-K - Current report
2021/03/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/08

重要事件披露

8-K - Current report
2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals